Centene receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Centene Corp (CNC)
The Centene share price today is 63.91, view NYSE CNC stock exchange data. Track the latest Centene share price with real-time updates on CNC stock performance including market cap, day range, 52-week range and dividend yield. Access CNC charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.67
64.92
52 wk Range
25.08
69.36
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.6764.92
52 wk Range
25.0869.36
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CNC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
65.17
Upside
+1.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
7 Buy
13 Hold
1 Sell
Ratings:
21 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 65.17
(+1.97% Upside)
Centene Corp SWOT Analysis
Enrollment Decline | Centene faces a projected 6% Medicaid enrollment decline through 2026, with mid-4% attrition rates challenging the company's core business model and scale advantages |
Medicare Strategy | The company pursues break-even status in Medicare Advantage amid prescription drug plan margin pressures creating a $0.74 negative earnings impact |
Analyst Outlook | Cantor Fitzgerald maintains a Neutral rating with a $41 price target, reflecting cautious sentiment amid membership losses and profitability challenges |
Market Position | Despite near-term headwinds, Centene's Medicaid expertise and government program relationships position the company to capitalize on demographic trends and potential enrollment stabilization |
Centene Corp Earnings Call Summary for Q2/2026
- Centene reported Q2 2026 adjusted EPS of $2.51, beating estimates by $1.44, but shares fell 8.15% as $0.50 came from non-recurring settlements.
- Revenue reached $53.58B, exceeding forecasts by $6B; full-year EPS guidance raised to over $4.80 from $3.40, though includes one-time gains.
- Health benefit ratio improved 340bps to 89.6% YoY; operating cash flow hit $8.0B YTD while debt-to-capital fell to 41.6% from 46.5%.
- Medicaid membership expected to decline 8-9% in 2026, worse than prior 6% forecast; Q3 to be slightly above breakeven, Q4 expected loss.
- Medicare Part D margins raised to over 3% from 2%; Marketplace margins increased to 4.5-5% from 3%; Medicare Advantage nearing breakeven for 2026.
Last Updated: 28-07-2026, 07:24 pm
Read Full TranscriptEarnings
Latest Release
28-07-2026
EPS / Forecast
2.51 / 1.07
Revenue / Forecast
53.58B / 47.63B
Compare CNC to Peers and Sector
Metrics to compare | CNC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCNCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.2x | −4.4x | −0.3x | |
PEG Ratio | 0.02 | 0.33 | 0.00 | |
Price/Book | 1.4x | 6.7x | 2.6x | |
Price / LTM Sales | 0.2x | 1.0x | 3.0x | |
Upside (Analyst Target) | 6.9% | 17.1% | 56.3% | |
Fair Value Upside | Unlock | 11.9% | 9.8% | Unlock |
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Centene (CNC) Share Price Today?
The Centene share price today is 63.91.
What is the current Centene (CNC) share price and day range?
As of 29-07-2026, the Centene share price is 63.91, with a previous close of 64.08. The share price has ranged from 56.67 to 64.92 today, while the 52-week range spans from 25.08 to 69.36.
What Is the Centene Market Cap?
As of today, Centene market cap is 31.57B.
What Is the Centene (CNC) Share Price Target?
The average 12-month share price target for Centene is 65.17, with a high estimate of 80 and a low estimate of 40. 7 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +1.97% Upside potential.
What Is Centene's Earnings Per Share (TTM)?
The Centene EPS (TTM) is -13.10.
When Is the Next Centene Earnings Date?
Centene will release its next earnings report on 27-10-2026.
From a Technical Analysis Perspective, Is CNC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Centene Trade On?
Centene is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Centene?
The stock symbol for Centene is "CNC."
How Many Times Has Centene Stock Split?
Centene has split 4 times.
How Many Employees Does Centene Have?
Centene has 61100 employees.
What Is the CNC Premarket Price?
CNC's last pre-market stock price is 59.67. The pre-market share volume is 4,32,370.00, and the stock has changed by -4.41, or -6.88%.
What Is the CNC After Hours Price?
CNC's last after hours stock price is 61.68, the stock has changed by -2.23, or -3.49%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.